Barry Freedman to Tissue and Organ Procurement
This is a "connection" page, showing publications Barry Freedman has written about Tissue and Organ Procurement.
Connection Strength
0.790
-
Freedman BI, Julian BA. Should kidney donors be genotyped for APOL1 risk alleles? Kidney Int. 2015 Apr; 87(4):671-3.
Score: 0.476
-
Freedman BI, Moxey-Mims M. The APOL1 Long-Term Kidney Transplantation Outcomes Network-APOLLO. Clin J Am Soc Nephrol. 2018 06 07; 13(6):940-942.
Score: 0.147
-
Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND, Palanisamy A, Reeves-Daniel AM, Brown WM, Divers J. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation. 2016 Jan; 100(1):194-202.
Score: 0.125
-
Young BA, Blacksher E, Cavanaugh KL, Freedman BI, Fullerton SM, Kopp JB, Umeukeje EM, West KM, Wilson JG, Burke W. Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions. Am J Nephrol. 2019; 50(4):303-311.
Score: 0.040